Sunstone Life Science Ventures

Sunstone Life Science Ventures

A venture capital and private equity firm investing in companies developing novel therapeutics for humans in Europe.

Sunstone Life Science Ventures venture capital and private equity firm investing in companies developing novel therapeutics for humans in Europe that is headquartered in Copenhagen, Denmark and was founded in 2007 by Søren Lemonius, Søren Lemonius, Søren Lemonius, Sten Verland, and Sten Verland.

Investments

Sunstone Life Science Ventures invests in life science companies developing therapeutics for humans; with a special interest in investing in companies developing specialty pharmaceuticals and orphan drugs. The firm does not invest in medical technologies such as medical diagnostic technologies. Sunstone Life Science Ventures focuses on investing in companies with clear exit strategies because it believes the most exits in the life science industry will occur through mergers and acquisitions.

Notable investments made by Sunstone Life Science Ventures include: IO Biotech, OxThera, Antargia, Adenium Biotech, Minervax, Galecto Biotech, Alligator Biosciences, Zeal & Revolutionary Health Solutions, Vaximm, Orphazyme, Ascella Pharma, Nuevolution, Symphogen, Evolva, Arcoma, FBC Device, Acarix, and Jenavalve.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Neo Technology (company)

Database
Acarix

Acarix is a Malmö-based company manufacturing diagnostic systems for coronary artery disease.

Healthcare
Malmö
JenaValve Technology

JenaValve Technology is an Irvine, California-based company.

Irvine, California
Forendo Pharma

4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Max Niederhofer

Board member

Nikolaj Nyholm

Employee

Yacine Ghalim

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.